The use of Cetirizine and Levocetirizine in patients with chronic urticaria and other allergic dermatoses: issues of dosage increasing and long-term use. Resolution of the Advisory Board

Autor: Larisa S. Kruglova, Andrey N. Lvov, Elena R. Araviyskaya, Andrey L. Bakulev, Aida G. Gadzhigoroeva, Elena S. Galimova, Inna V. Danilychevа, Olga G. Elisyutina, Oleg R. Ziganshin, Natalia I. Ilina, Muza M. Kokhan, Elena V. Matushevskaya, Natalia B. Migacheva, Nikolay N. Murashkin, Olga B. Nemchaninova, Natalia M. Nenasheva, Olga Yu. Olisova, Elena B. Pavlinova, Olga A. Pritulo, Marina N. Repetskaya, Alexey V. Samtsov, Olga A. Sidorenko, Elena S. Snarskaya, Evgeny V. Sokolovskiy, Olga B. Tamrazova, Natalia S. Tataurshchikova, Elena S. Fedenko, Natalia V. Fedotova, Natalia V. Shartanova, Luiza A. Yusupova
Rok vydání: 2022
Předmět:
Zdroj: Russian Journal of Allergy. 19:388-403
ISSN: 2686-682X
1810-8830
2307-3586
Popis: This article reflects the main issues discussed at the Advisory Board with the participation of leading dermatovenereologists, allergists, and immunologists. The Advisory Board has become a platform for discussing the accumulated clinical and organizational problems in the field of managing patients with chronic urticaria and other allergic dermatoses. The Advisory Board also discussed the possibility of long-term use of cetirizine and levocetirizine and the use of their high doses in clinical practice. The subject of discussion was the question of the algorithm for escalation and subsequent de-escalation of the dose of non-sedating H1 antihistamines. An algorithm for escalation and de-escalation of doses of antihistamines was created based on the discussion, which can be recommended for use in clinical practice. This article was simultaneously published in several journals with permission from authors and publishers. The parallel publication is available here: The use of cetirizine and levocetirizine in patients with chronic urticaria and other allergic dermatoses: Issues of dosage increasing and long-term use from the resolution of the Advisory Board. Effective Pharmacotherapy. 2022;18(25):614. DOI: https://doi.org/10.33978/2307-3586-2022-18-25-6-14. This article published with permission from authors and copyright holder.
Databáze: OpenAIRE